HSPE1 and central nervous system cancer: Complementing these deficits observed in in vitro functional assays, clinical validation utilizing the Human Protein Atlas (HPA) database revealed significant overexpression of HSPE1 in glioma specimens compared to normal brain tissue, which was further confirmed by immunohistochemical (IHC) analysis of tissue microarrays (Figures 10H, I).